Company / Cost of Revenue
MIMEDX GROUP, INC. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$73.0M
FY2025
5-year range
$39.6M / $73.0M
FY2021-FY2025
Trend
+21.5%
vs FY2024
Sector context
#94 of 110
Health Care
What the data says
MIMEDX GROUP, INC.'s cost of revenue of $73M is lower than 85% of companies in the Health Care sector (FY2025). Cost of Revenue has increased for 5 consecutive years, from $39M in FY2020 to $73M in FY2025.
Based on SEC 10-K filings.
$73M in FY2025 with a 5-year CAGR of +13.2%.
Increased from $55M to $73M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +14.8%
- 5-Year CAGR
- +13.2%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 110This company $73.0M Sector average $11.5B
▼
-99.4% below sector average
Key checks
Key Insights
- MIMEDX GROUP, INC.'s cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +13.2%, indicating consistent growth.
- In FY2025, cost of revenue increased 21.5% year-over-year.
- Ranks #94 out of 110 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.50 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $73.0M | +21.5% |
| FY2024 | $60.1M | +10.0% |
| FY2023 | $54.6M | +13.1% |
| FY2022 | $48.3M | +21.9% |
| FY2021 | $39.6M | +0.8% |
| FY2020 | $39.3M | -8.7% |
| FY2019 | $43.1M | +18.4% |
| FY2018 | $36.4M | +3.3% |
| FY2017 | $35.2M | +13.8% |
| FY2016 | $30.9M | +53.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026